Abstract
Hypertension in middle-aged or elderly women is often accompanied with various symptoms, which may be related to climacteric. The symptoms of post-menopausal women are suggested to be derived in part from instability of the sympathetic nerve system due to a low estrogen state. An angiotensin-receptor blocker, candesartan cilexetil (candesartan), is known to suppress sympathetic nerve activity by inhibiting the renin-angiotensin system in the brain, suggesting that it may be effective for ameliorating these symptoms. The aim of this study was to elucidate whether candesartan improves menopausal symptoms in hypertensive women. A total of 69 female patients, aged 40 years or older, who had hypertension and various menopausal-like symptoms, were recruited from 39 centers to participate in this study. Patients were prescribed candesartan 4 to 8 mg/day (average dose 7.2 mg/day), alone or in addition to current antihypertensive medications. We interviewed patients in regard to their menopausal symptoms and scored them using the Simplified Menopausal Index (SMI). During the 12-month observation period, significant decreases were seen in both blood pressure (157±21/85±11 to 141±18/77±12 mmHg, p<0.001) and SMI (29±18 to 18±17, p<0.001), although the heart rate did not change. The percentage of decrease in SMI was correlated with that in systolic blood pressure (r=0.43, p<0.001). Candesartan may be an effective antihypertensive agent to relieve menopausal-like symptoms in middle-aged or elderly hypertensive women.
Similar content being viewed by others
Article PDF
References
Takamatsu K, Ohta H, Makita K, et al: Effects of counseling on climacteric symptoms in Japanese postmenopausal women. J Obstet Gynecolol 2001; 27: 133–140.
Saavedra JM, Ando H, Armando I, et al: Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regul Pept 2005; 128: 227–238.
Koyama T : Climacteric disorders. Obstet Gynecol Ther 1994; 69: 506–509 ( in Japanese).
Bradshaw K : Hormone replacement therapy in hypertensive postmenopausal women. Role of the gynecologist. in Safer M, Stimpel M, Zanchetti A ( eds): Hypertension in Postmenopausal Women. Berlin and Heidelberg, Springer-Verlag, 1994, pp 45–51.
Stacssen J, Bulpitt CJ, Fagard R, et al: The influence of menopause on blood pressure. J Hum Hypertens 1989; 3: 427–433.
Anastos R, Charney P, Charon RA, et al, The Women's Caucus, Working Group on Women's Health of the Society of Geneal Internal Medicine: Hypetension in women: what is really known? Ann Intern Med 1991; 115: 287–293.
Hjemdahl P, Wiklund I : Quality of life on antihypertensive drug therapy: end point or marketing exercise? Hypertension 1992; 10: 1437–1446.
Barnet DB : Assessment of quality of life: a medical imperative. Am J Cardiol 1991; 67: 41C–44C.
Wenger NK : Assessment of quality of life: a medical imperative. Cardiovasc Drug Ther 1988; 1: 553–558.
Dahlöf B, Innocenti AD, Elmfeldt D, et al: Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction. Am J Hypertens 2005; 18: 1313–1319.
Schulte KL, Fischer M, Lenz T, et al: Efficacy and tolerability of candesartan cilexetil monotherapy or in combination with other antihypertensive drugs: results of the AURA study. Clin Drug Invest 1999; 18: 453–460.
Malmqvist K, Kahan T, Dahl M : Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. Am J Hypertens 2000; 13: 504–511.
Kloner RA, Weinberger M, Pool JL, et al: Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Am J Cardiol 2001; 87: 727–731.
Kirpizidis H, Stavrati A, Geleris P : Assessment of quality of life in a randomized clinical trial of candesartan only or in combination with DASH diet for hypertensive patients. J Cardiol 2005; 46: 177–182.
Mercuro G, Zonc S, Pilia I, et al: Effects of acute administration of transdermal estrogen on postmenpausal women with systemic hypertension. Am J Cardiol 1997; 80: 652–655.
Owada K : Efficacy of candesartan in the treatment of migraine in hypertensive patients. Hypertens Res 2004; 27: 441–446.
Nickenig G, Bäumer AT, Grohe C, et al: Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 1998; 97: 2197–2201.
Suzuki H, Kanno Y, for the Efficacy of Candesartan on Outcome in Saitama Trial (E-COST) Group: Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients. Hypertens Res 2005; 28: 307–314.
Pfeffer MA, Swedberg K, Granger CB, et al: Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362: 759–766.
McMurray JJ, Ostergren J, Swedberg K, et al: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003; 362: 767–771.
Yusuf S, Pfeffer MA, Swedberg K, et al: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 2003; 362: 777–781.
Lithell H, Hanson L, Skoog I, et al: The Study on Cognition and Prognosis in Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 2003; 21: 875–886.
Dohi Y, Ohashi M, Sugiyama M, et al: Candesartan reduces oxidative stress and inflammation in patients with essential hypertension. Hypertens Res 2003; 26: 691–697.
Kubota T, Sagara Y, Nakazawa N, et al: The influence of pregnancy and delivery on the climacteric symptom. Acta Obstet Gynaecol Jpn 1996; 48: 1–8 ( in Japanese).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ikeda, H., Inoue, T., Uemura, S. et al. Effects of Candesartan for Middle-Aged and Elderly Women with Hypertension and Menopausal-Like Symptoms. Hypertens Res 29, 1007–1012 (2006). https://doi.org/10.1291/hypres.29.1007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.1007
Keywords
This article is cited by
-
Effect of Vitamin-Containing Amino Acid Supplements on Menopausal Symptoms and Age-Related Skin Changes: A Randomised, Double-Blind, Placebo-Controlled Study
Dermatology and Therapy (2021)
-
Gender differences in coronary heart disease
Netherlands Heart Journal (2010)
-
Women’s health in menopause with a focus on hypertension
Netherlands Heart Journal (2009)